EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 18, Issue 1
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Regional News

In a busy month, Pfizer extends recall of blood pressure meds to the UK

Add another country to the recall list for Pfizer’s blood pressure medicines. Monday, the company pulled one lot of Accuretic off shelves in the U.K., continuing ...
30 March 2022 Regional News blood | meds
Continue Reading →
Regional News

Pfizer recalls 2nd blood pressure med in a week, again on potential carcinogen fears

Pfizer issued a second round of Canadian recalls this week as the country’s drug regulator continues to weed out meds with an excess of potential cancer-causing impur...
9 March 2022 Regional News blood | carcinogen
Continue Reading →
Europe

Scientists develop the first blood test for melanoma detection

The new blood test detects the autoantibodies produced in the body in response to the melanoma. Scientists at the Edith Cowan University (ECU), Australia, have devel...
25 July 2018 Europe blood | detection
Continue Reading →
Europe

VarmX Raises € 12.5 Million to Develop Modified Blood Coagulation Factor X for Treating Severe Bleeding in Patients Using Anti-Coagulants Funding enables clinical stage trials of lead compound PseudoXa

€ 7.5 million Series A financing from lead investor BioGeneration Ventures (BGV) and Dutch regional development company InnovationQuarter Financing supplemente...
4 July 2018 Europe 12.5M | blood
Continue Reading →
Europe

Significant blood sugar improvement with Xultophy® compared to insulin glargine U-100 when used as add-on to oral diabetes medications

Adults with type 2 diabetes treated with Xultophy® (insulin degludec and liraglutide injection) also experienced no change in body weight, lower rates of hypoglycaem...
27 June 2018 Europe blood | compared
Continue Reading →
Europe

Oral semaglutide demonstrated significant reduction in blood sugar vs placebo in PIONEER 1 trial

Oral semaglutide, an investigational GLP-1 analogue taken as a once-daily tablet, achieved significant reductions in blood sugar versus placebo in adults with type 2 ...
27 June 2018 Europe blood | demonstrated
Continue Reading →
news

Proteomics and Dimerix partner to improve the treatment of kidney disease

Australia-based Proteomics International (PI) has developed PromarkerD, a predictive and diagnostic test for diabetic kidney disease that measures a protein biomarker...
20 December 2017 news biomarker | blood
Continue Reading →
Catalyst: 12th January 2026
Quotient

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte